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In the bovine ovary there is a delay of 4-6 days between the observed maximum of oxytocin mRNA and 
the peak in the luteai levels of oxytocin nonapeptide. This implies a maturation process involving compo- 
nents of the post-translational processing pathway. In situ hybridization shows the oxytocin gene to be 
transcribed exclusively in the large cells of the corpus luteum at the beginning of the estrous cycle. 
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1. INTRODUCTION 
Although the nonapeptide oxytocin is primarily 
thought of as a neurohypophyseal hormone syn- 
thesized within the magnocellular nuclei of the 
hypothalamus, it has recently also been identified 
within several peripheral tissues, including the 
gonads. In particular, the ruminant corpus luteum 
has been shown to be especially rich in the hor- 
mone, releasing large quantities into the ovarian 
vein during the latter half of the estrous cycle, 
probably in response to the luteolytic secretion of 
prostaglandin Fti by the uterus [l-3]. 
Sequence analysis showed that luteal oxytocin 
was the product of the same gene as in the 
hypothalamus, with an identical mRNA except 
that its polyadenyl tail was shorter [4]. Oxytocin 
mRNA levels measured through the estrous cycle 
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indicated that the gene was transcribed 
predominantly in the first days after ovulation [5]. 
Yet oxytocin peptide levels measured in other 
studies [3,6] suggested peptide maxima at mid- 
cycle. Thus the preliminary luteal data point to a 
marked discrepancy between the appearance of 
mRNA and that of the processed peptide. This is 
in contrast to the hypothalamic situation where 
radiolabelled oxytocin or vasopressin appear in the 
neurohypophysis only hours, not days, after injec- 
tion of [35S]cysteine into the hypothalamic nuclei 
[7-91. 
Using cows of known cycle date we have ana- 
lysed both oxytocin mRNA and oxytocin peptide, 
within the same corpora lutea, to establish whether 
the bovine corpus luteum indeed exhibits a delay 
between transcription and appearance of the pro- 
cessed hormone. Transcription of the gene was 
measured either by dot-blot analysis or by in situ 
hybridization. The latter method allows precise 
localization of the cells where the respective gene is 
expressed. 
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2. MATERIALS AND METHODS 
2.1. RNA preparation and assay 
Corpora lutea were collected from Fleckvieh 
cows of known estrous date within 20 min of 
death, and frozen immediately in liquid nitrogen. 
Later, RNA was prepared from a portion of these 
by the guanidinium isothiocyanate procedure as in 
[S]. 10 pg aliquots of this RNA were applied to a 
nitrocellulose filter using a slot manifold, and 
hybridized as described [5] with the oxytocin- 
specific probe (OT-3 ’ [4]), labelled by nick transla- 
tion to a specific activity of 3 x lo6 cpm/pg. 
Single-stranded ml3 DNA into which the sense 
strand of the OT-3 ’ probe had been subcloned was 
used as calibration standard. After autoradio- 
graphic exposure for 4 h, exposed film was den- 
sitometrically scanned to quantitate the relative 
amounts of mRNA and calibration standard. 
2.2. U~yfuei~ and progesterone measurement 
Both oxytocin and progesterone were measured 
in extracted portions of the same corpora lutea, 
as above, using radioimmunoassays described 
elsewhere [3]. 
2.3. In situ hybridization 
Oxytocin (OT-3 ‘) and vasopressin (VP-3 ‘) (see 
[4]) specific probes were subcloned into the 
plasmid pSP 64. Labelled single-stranded cRNA 
was obtained by transcription with [3’S]thio-GTP 
(Amersham Sp6 system) to give specific activities 
of 5 x IO* cpmlfcg. 
Corpora lutea of different days of the estrous 
cycle were obtained from Angus cross-bred cows 
of known cycle date, within 15 min of death, 
embedded in Tissue Tek mounting fluid and im- 
mediately frozen in liquid nitrogen. 6 pm cryostat- 
cut sections were mounted on cold 3 ’ aminopro- 
pyitriethoxysilane (Sigma) treated slides [lo] and 
stored at -80°C. The tissue was not warmed at 
any stage of the preparation. 
In situ hybridization was performed as described 
[ 111 with the following modi~cations: Slides were 
placed into freshly prepared 4% parafor- 
maldehyde in phosphate-buffered saline (PBS) for 
5 min, washed twice in PBS for 5 min each and 
then dehydrated by placing them for 5 min each in- 
to successively 60, 80,95 and 100% ethanol. Slides 
were then dried in a vacuum desiccator. 
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Prehybridization buffer contained 50% deionized 
formamide, 0.75 M NaCI, 0.025 M EDTA, 
0.025 M Pipes, pH 6.8, 5 x Denhardt’s, 0.2% 
SDS, 10 mM dithiothreitol, 250gg/ml denatured 
herring sperm DNA, and 250/1g/ml yeast tRNA. 
Hybridization buffer contained in addition 10% 
dextran sulfate. 1 ml prehybridization buffer was 
then applied to each slide. These were placed flat 
into boxes lined with filter paper soaked with 50% 
formamide, and incubated for 3 h at 50°C. 
Prehybridization buffer was drained by tapping 
the edge of the slide against filter paper. 70~1 
hybridization buffer containing 4 ng probe (1.7 x 
ov. 
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Fig. I. Levels of oxytocin mRNA (A), oxytocin peptide 
(B) and progesterone (C) in individual corpora lutea 
taken from cows of known estrous date. Individual 
vaIues are shown as verticai bars in the main histograms. 
3-day means are shown as insets. Because of the large 
number of samples collected for progesterone 
determination on day 21, these values are represented by 
a circle (mean) and a vertical (range). ov., day of new 
ovulation. 
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lo6 cpm) was applied to the tissue and coverslips 
were placed onto the slides and sealed with Pattex 
(Henkel KG, Diisseldorf). Hybridization was car- 
ried out at 50°C overnight in the tape-sealed filter- 
lined boxes. 
After hybridization, coverslips were removed 
and the sections washed by dipping the slides into 
4 x SSC containing 20 mM ,&-mercaptoethanol. 
After two such washes and two washes in 4 x SSC 
only, each of 5 min, the slides were placed into 
buffer (0.5 M NaCl, 10 mM Tris-HCl, pH 7.5, 
1 mM EDTA) containing 40pg/ml RNase A 
(Boehringer) and incubated for 30 min at 37°C. 
Slides were washed once in the same buffer 
without RNase A for 30 min at 37°C and then 
twice in 2 x SSC for 15 min at 5O”C, dehydrated 
through 60, 80, 95 and 100% ethanol and dried in 
a vacuum desiccator. 
The dried slides were exposed to X-ray film 
(Cronex) or dipped into Kodak NTB-3 nuclear 
track emulsion at 42°C. After exposure at 4°C for 
between 4 days and 2 weeks as indicated in the 
figure legends, autoradiograms were developed 
with Kodak chemicals, counterstained with 
hematoxylin eosin and coverslipped. 
3. RESULTS 
3.1. Delay in the appearance of oxytocin peptide 
The bovine corpus luteum results from the 
massive tumor-like proliferation of the granulosa 
Fig.2. Oxytocin mRNA-specific in situ hybridization of bovine corpora lutea from various days of the non-pregnant 
cycle, and from pregnancy. A, day 3; B, day 11; C, day 19; D, pregnancy. Exposure for 2 weeks. Black bars, 1 pm; 
white bars, 3 mm. 
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and theta cell layers of the follicle from which the 
newly released oocyte has escaped. Necessarily this 
luteinization process is accompanied by con- 
siderable gene transcription [5]. One of these early 
genes is that for oxytocin (fig.lA) for which max- 
imum mRNA levels are found in the first 6 days of 
the cycle, thereafter levels being reduced to basal 
amounts. The rapid decline from one day to the 
next around day 7 presumably reflects the relative- 
ly short haIf-life typical of most mRNAs. 
It is a characteristic of the bovine corpus luteum 
that there is much variation between animals. This 
reflects the individual rates of biochemical activity 
within each animal, some cows having an mRNA 
or hormone production days in advance of others. 
For this reason, both individual data as well as 
pooled means are illustrated, to indicate the extent 
of variation and trends, respectively. 
Fig. 1B shows the accumulation of oxytocin pep- 
tide in the corpus luteum, using a radioim- 
munoassay system based on an antibody raised 
against the C-terminally amidated nonapeptide. 
The histogram indicates that there is no correla- 
tion between the level of oxytocin mRNA and that 
of peptide within any one corpus luteum (cf. 
panels A and B). The trend is however evident: 
there is a marked delay in the m~imum ap- 
pearance of oxytocin peptide of some 6-7 days 
following the maximum appearance of oxytocin 
mRNA. 
The principal steroidogenic function of the cor- 
pus luteum is indicated in the progesterone content 
(fig. lC), where maximum levels accumulate in the 
latter, luteolytic half of the cycle, offering a dif- 
ferent profile from those for oxytocin and its 
mRNA. 
- 
# 
.A a * 
Fig.3. In situ hybridization of a day 3 bovine corpus luteum, exposed for only 2 days. I.., large luteal cell; S, small iuteal 
celIs. Black bar, 1 gm. 
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3.2. In situ hybridization of oxytocin mRNA 4. DISCUSSION 
Cryotome sections of bovine corpora lutea from 
various stages of the non-pregnant cycle as well as 
from pregnancy were prepared for in situ 
hybridization with single-stranded cRNA probes 
specific for oxytocin mRNA as described in section 
2. The use of RNA single-stranded probes of high 
specific activity and subsequent RNase treatment 
of sections to reduce background significantly in- 
creased the sensitivity of this methodology. In 
macroscopic, dark-field view (fig.2, insets), the 
sections, which have been hybridized and 
autoradiographically exposed in parallel, indicate 
a high level of oxytocin gene expression on day 3 
The current view on the genesis of the corpus 
luteum is that, accompanying ovulation, the cells 
of the follicular wall proliferate and involute with 
the inner granulosa layer forming the large luteal 
cells, and the outer theta layer giving rise to the in- 
terstitial small cells. As the cycle progresses the 
number of granulosa-derived large cells, based on 
expression of specific surface antigens, declines 
and theta-derived cells enlarge and replace the 
former cells [12]. In pregnancy the majority of 
cells are then of thecal origin. 
- white areas are the silver grains resulting from 
the mRNA-positive hybridization signals. The hy- 
bridizing cells belong at this young luteal stage to 
the layers of involuting and proliferating follicle 
wall. The dark areas are occupied by small epi- 
thelial cells, blood vessels and connective tissue. In 
the later corpora lutea (fig.2), there is clearly much 
less oxytocin mRNA and the convoluted gross 
anatomy gradually disappears. 
At the microscopic level, here in normal incident 
illumination with only cell nuclei visualized by 
hematoxylin staining (figs 2,3), silver grains are 
localized in the cytoplasm, forming a halo around 
the larger, more lightly staining nuclei, belonging 
to the large luteal cells. 
A basal expression of the oxytocin gene in- 
cluding the secretion of the nonapeptide is 
associated with the granulosa layer of the 
preovulatory follicle [ 13,141. Upon ovulation, 
there is a massive up-regulation of the oxytocin 
gene to high expression in the same cells, now part 
of the corpus luteum. No new cell types have 
started expressing the gene, agreeing with im- 
munohistochemical observations [ 15,161. The up- 
regulation is maintained only for a few days, and 
as demonstrated by the considerable drop in the 
oxytocin mRNA pool, is then cancelled, even 
though other metabolic processes of the corpus 
luteum, such as steroidogenesis (fig.lC) are main- 
tained well into the latter half of the cycle. 
Comparing the microscopic distribution of ox- 
ytocin mRNA through the cycle shows firstly that 
this mRNA is confined to the large luteal cells, 
small cells, connective tissue and blood vessels be- 
ing negative. Secondly, the quantitative decline in 
oxytocin mRNA is due to both a decrease in levels 
within individual large cells and to a reduction in 
the number of cells giving positive signals. As ex- 
pected, very few positive cells could be identified in 
tissue from the luteolytic half of the cycle, and 
none at all from the corpus luteum of pregnancy 
(fig.2). A control using a cRNA probe specific for 
the vasopressin gene product (not shown) was also 
negative; levels of vasopressin mRNA are present 
in the bovine corpus luteum in lOOO-fold lower 
amounts than those of the oxytocin-specific 
transcript ([4]; Ivell and Morley, unpublished), but 
lie below the detection limits of the in situ 
hybridization technique. 
However, what cannot be explained is the delay 
of 4-6 days between the peak of the mRNA pool 
and that of oxytocin peptide. Eucaryotic mRNAs 
generally have half-lives of only a few hours; ox- 
ytocin mRNA appears to be no exception as seen 
in the rapid drop in mRNA levels after day 6. In 
the hypothalamo-neurohypophyseal system, in 
vivo biosynthesis of oxytocin or vasopressin by 
translation of mRNA, processing and slow axonal 
transport over a long neuronal distance, has been 
measured in the rat [7,8] and dog [9] requiring 
altogether some 2 to 6 h, respectively. Therefore, 
to account for a delay in the appearance of ox- 
ytocin nonapeptide of several days there must be a 
delay at either the translational or post- 
translational evel. 
Electron microscopy reveals dense granule for- 
mation already at day 3, some of which are im- 
munoreactive for neurophysin [16], the other 
component of the oxytocin precursor polyprotein. 
The number of such granules increases to a max- 
imum at about day 11 [16], corresponding to the 
49 
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peak of oxytocin observed here. The most likely 
explanation is therefore that the rapid cell pro- 
liferation characterizing luteinization and the 
growth of the bovine corpus luteum from -0.1 g 
on day 1 to -5 g on day 7 [5] is not accompanied 
by an equivalent increase in the elements and en- 
zymes of the post-translational processing 
pathway. This system must ‘mature’ before the 
translated precursor can be converted into the 
physiologically active nonapeptide packaged into 
secretory granules and ready for release. A similar 
maturation has been suggested to account for the 
varying ratios of neurophysin to nonapeptide im- 
munoreactivity in the developing human embryo 
1171, or in primary cell cultures of rat 
hypothalamus [ 181. 
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